c-Met-IN-14, a N-sulfonylamidine-based derivative, is a selective c-Met kinase inhibitor with an IC50 value of 2.89 nM. It exhibits anticancer properties by inhibiting c-Met phosphorylation and arresting the cell cycle at the G2/M phase. Additionally, c-Met-IN-14 promotes dose-dependent apoptosis in A549 cells.
Molekulargewicht:
701.2
CAS Nummer:
[2443380-34-3]
Formel:
C34H38ClFN4O7S
Target-Kategorie:
c-Kit|||FLT|||Apoptosis|||c-Met/HGFR|||Others
T73022
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten